HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jorge M Alves-Silva Selected Research

Antitussive Agents (Antitussives)

10/2018New insights on the anti-inflammatory potential and safety profile of Thymus carnosus and Thymus camphoratus essential oils and their main compounds.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jorge M Alves-Silva Research Topics

Disease

4Cardiovascular Diseases (Cardiovascular Disease)
06/2021 - 12/2014
2Neoplasms (Cancer)
04/2023 - 01/2017
2Wounds and Injuries (Trauma)
04/2023 - 01/2023
2Mycoses (Diseases, Fungus)
01/2023 - 05/2021
2Pulmonary Arterial Hypertension
01/2023 - 01/2022
1Hyperpigmentation
10/2023
1Fibrosis (Cirrhosis)
01/2022
1Hypertrophy
01/2022
1Cardiomegaly (Heart Hypertrophy)
01/2019
1Reperfusion Injury
01/2019
1Inflammation (Inflammations)
10/2018
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2016
1Heart Failure
01/2016
1Hypertension (High Blood Pressure)
01/2016

Drug/Important Bio-Agent (IBA)

2Etoposide (VP 16)FDA LinkGeneric
10/2023 - 04/2023
2Antifungal AgentsIBA
01/2023 - 05/2021
2Connexin 43 (Connexin43)IBA
01/2023 - 01/2022
2EucalyptolIBA
01/2023 - 01/2022
2FlavonesIBA
01/2015 - 12/2014
1T0901317IBA
10/2023
11-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA
10/2023
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2023
1GalactosidasesIBA
01/2023
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2023
1MonocrotalineIBA
01/2022
1Volatile Oils (Essential Oils)IBA
06/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2019
1Vasodilator Agents (Vasodilators)IBA
01/2019
1Antitussive Agents (Antitussives)FDA Link
10/2018
1Terpenes (Terpenoids)IBA
01/2016

Therapy/Procedure

3Therapeutics
04/2023 - 01/2017